141 related articles for article (PubMed ID: 11959606)
1. In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages.
González GM; Tijerina R; Sutton DA; Graybill JR; Rinaldi MG
Antimicrob Agents Chemother; 2002 May; 46(5):1583-5. PubMed ID: 11959606
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.
Johnson EM; Ojwang JO; Szekely A; Wallace TL; Warnock DW
Antimicrob Agents Chemother; 1998 Jun; 42(6):1412-6. PubMed ID: 9624486
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.
Cordeiro RA; Brilhante RS; Rocha MF; Fechine MA; Costa AK; Camargo ZP; Sidrim JJ
Mycopathologia; 2006 Jan; 161(1):21-6. PubMed ID: 16389480
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas.
Ramani R; Chaturvedi V
Mycopathologia; 2007 Jun; 163(6):315-9. PubMed ID: 17484074
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
[TBL] [Abstract][Full Text] [Related]
6. Large-Scale Evaluation of
Thompson GR; Barker BM; Wiederhold NP
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.
Arikan S; Ostrosky-Zeichner L; Lozano-Chiu M; Paetznick V; Gordon D; Wallace T; Rex JH
J Clin Microbiol; 2002 Apr; 40(4):1406-12. PubMed ID: 11923365
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
Hoeprich PD; Huston AC
J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
[TBL] [Abstract][Full Text] [Related]
9. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis.
Clemons KV; Stevens DA
J Antimicrob Chemother; 1992 Sep; 30(3):353-63. PubMed ID: 1452501
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal activity of clotrimazole (Bay b 5097).
Shadomy S
Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antifungal activity of isoniazid-derived hydrazones against Coccidioides posadasii.
Cordeiro Rde A; de Melo CV; Marques FJ; Serpa R; Evangelista AJ; Caetano EP; Mafezoli J; de Oliveira Mda C; da Silva MR; Bandeira Tde J; Moreira JL; Brilhante RS; Rocha MF; Sidrim JJ
Microb Pathog; 2016 Sep; 98():1-5. PubMed ID: 27334293
[TBL] [Abstract][Full Text] [Related]
12. Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2004 Jun; 48(6):2140-3. PubMed ID: 15155212
[TBL] [Abstract][Full Text] [Related]
13. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
[TBL] [Abstract][Full Text] [Related]
14. [A case of coccidioidomycosis in Turkey imported from the United States of America].
Başaran S; Karabıçak N; Şimşek Yavuz S; Wiederhold NP; Şafak S; Sarıbuğa A; Sutton DA; Bingöl Z; Çağatay A; Özsüt H; Kılıçaslan Z; Eraksoy H
Mikrobiyol Bul; 2017 Apr; 51(2):183-190. PubMed ID: 28566083
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Zygomycota to polyenes.
Dannaoui E; Meis JF; Mouton JW; Verweij PE;
J Antimicrob Chemother; 2002 May; 49(5):741-4. PubMed ID: 12003966
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae.
Lass-Flörl C; Nagl M; Gunsilius E; Speth C; Ulmer H; Würzner R
Mycoses; 2002 Jun; 45(5-6):166-9. PubMed ID: 12100533
[TBL] [Abstract][Full Text] [Related]
17. Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.
Huppert M; Pappagianis D; Sun SH; Gleason-Jordan I; Collins MS; Vukovich KR
Antimicrob Agents Chemother; 1976 Mar; 9(3):406-13. PubMed ID: 1259400
[TBL] [Abstract][Full Text] [Related]
18. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.
González GM; Tijerina R; Najvar LK; Bocanegra R; Luther M; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2001 Jun; 45(6):1854-9. PubMed ID: 11353637
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of posaconazole against Coccidioides immitis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi M; Loebenberg D; Graybill JR
Antimicrob Agents Chemother; 2002 May; 46(5):1352-6. PubMed ID: 11959568
[TBL] [Abstract][Full Text] [Related]
20. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Clemons KV; Homola ME; Stevens DA
Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
